Madam T has been having recurrent strokes
every year for the last four years. In the past six months alone, she was
incapacitated by the development of two new strokes. Her latest stroke occurred
about two months ago and left her with slurred speech and partial weakness.
She
first turned up in my clinic soon after the latest stroke. Although she had
mild weakness, she managed to walk into my clinic without any assistance, but
she was particularly frustrated with her slurred speech and inability to
express herself. What was obvious was that she had a fast and irregular heart
rhythm, atrial fibrillation (AF), which explained why she had recurrent
strokes.
In AF,
electrical impulses are being generated in the atria (upper chambers) in a
chaotic manner at a rate of about 400 per minute. The impact of this is that
the atria are effectively just "quivering". The inflowing blood will
slow down considerably when entering the left upper heart chamber (LA).
In the
LA, there is a blind pouch called the atrial appendage (LAA). The blood
entering into this area may slow down so significantly that it may stagnate and
result in the formation of blood clots. Blood clots in the LAA may occasionally
be dislodged by incoming blood flow and the dislodged blood clot may traverse
into the main artery, the aorta, and thereafter into the neck arteries leading
to the brain, resulting in a stroke.
While
an occasional skipped heart beat may not mean much, one must not be too hasty
to dismiss the presence of an irregular pulse which does not seem to have any
particular rhythmic pattern. The accompanying symptoms of AF are not specific
and may include palpitations, dizzy spells, breathlessness and near fainting.
If these symptoms are present in association with an irregular heart rhythm,
the presence of AF can easily be confirmed with an electrocardiogram (ECG)
which is a recording of the electrical pattern of the heart.
Dangers of irregular heart rhythm
The
presence of AF is not to be taken lightly as it is associated with a higher
risk of stroke, heart failure and death. Fortunately, AF prevalence is
relatively low, being present in about one per cent of the population, and
mainly in those above the age of 60. The prevalence increases with age,
increasing to 8 per cent in those above 80. Once AF becomes a recurring event,
the incidence of stroke averages about 5 per cent annually. If
"silent" strokes detected by brain scans are included, the rate of
stroke associated with AF exceeds 7 per cent annually. Furthermore, strokes
resulting from blood clots that arise from the heart as a result of AF are
usually severely disabling and associated with a high risk of death.
The
age-old adage "prevention is better than cure" is especially true for
AF. Common medical conditions such as high blood pressure, diabetes mellitus,
obstructive sleep apnoea and excessive thyroid hormones, as well as obesity and
lifestyle choices such as alcohol consumption and endurance exercise training
increase the likelihood of developing AF. Lifestyle changes may potentially
reduce these risks in some cases.
Medication or invasive procedure?
Drugs
are currently the recommended first line of therapy. Using drugs to keep the
heart rhythm "normal", or in the case of persistent AF, using drugs
to prevent the heart rate from being high appears to result in similar outcomes
with no difference in mortality or stroke rate.
In
addition, blood thinning agents are often used to decrease the likelihood of
blood clot formation in the LA. For those who fail to respond to drugs and
remain significantly symptomatic, an invasive technique, catheter ablation,
where special electrodes are inserted through veins and manipulated into the
heart to map out the source of AF, and to electrically isolate the source or
burn away the source of the AF, is an alternative option.
Burning question
A
difficult question facing doctors is whether patients with AF should be sent
for catheter ablation, given that there are potential benefits if the source of
AF can be "burnt" away. In the 2012 expert consensus statements on
catheter ablation of AF published in the Europace journal, the authors caution
that while there are several hypothetical reasons to perform AF ablation
procedures, including potential improvement in quality of life, reduced stroke
risk, reduced heart failure risk and improved survival, these reasons
"have not been systematically evaluated as part of a large randomised
clinical trial and are therefore unproven". It is important to recognise
that the primary justification for an AF ablation procedure at this time is the
presence of symptomatic AF after failure to respond to drugs.
Reasons
for this cautionary approach include a high reported complication rate of 6 per
cent (based on a first worldwide voluntary survey) and the high incidence of
recurrence after ablation. Complications include death, life-threatening heart
complications and strokes.
The
complication rate is higher if new silent strokes seen on Magnetic Resonance
Imaging brain scans after AF ablation procedures are included (a range of 7 to
38 per cent; mean 17 per cent). An important but less obvious potential complication
is the delayed effect of the radiation received by the patients, including skin
injury, cancer and genetic abnormalities.
Catheter
ablation of AF is a complex procedure requiring a long X-ray imaging time
(usually more than 60 minutes ) and is often preceded and followed by Computed
Tomography X-ray scans which contribute further to the radiation exposure.
The
other major challenge is to improve the technology to prevent recurrences. In a
five-year follow-up study after AF ablation published in the Journal of the
American College of Cardiology in 2011, 40 per cent were free of abnormal heart
rhythms after one year, and at five years only 29 per cent remained free of
abnormal rhythms. The high complication rate, high radiation dose and high AF recurrence
rate mean that further developments are needed to address these issues.
Madam T
came for her review a few days ago and her strength and speech had improved
significantly. Most importantly, her heart rhythm was normal and her stroke
risk had diminished considerably. Perhaps, if she had paid more attention to
her palpitations years ago, she would not have had multiple strokes.
Nevertheless, it was not too late for her to start paying attention to her
palpitations.
Dr
Michael Lim is medical director at the Singapore Heart, Stroke & Cancer
Centre. He is also editor-in-chief, Heart Asia; British Medical Journals
Publishing Group, chairman; Scientific Advisory Board, Asia Pacific Heart
Association honorary professor and senior medical adviser, Peking University
Heart Centre.
This
series is brought to you by the Heart, Stroke and Cancer Centre.
Dr
Michael Lim
The
Business Times
No comments:
Post a Comment